Citation

Sahlem GL, Kalivas B, Fox JB, Lamb K, Roper A, Williams EN, Williams NR, Korte JE, Zuschlag ZD, El Sabbagh S, Guille C, Barth KS, Uhde TW, George MS, Short EB. J. Psychiatr. Res. 2014; 59: 101-107.

Affiliation

Departments of Psychiatry, Medical University of South Carolina, 67 President Street, Charleston, SC, USA; Departments of Medicine, Medical University of South Carolina, 67 President Street, Charleston, SC, USA.

Copyright

(Copyright © 2014, Elsevier Publishing)

DOI

10.1016/j.jpsychires.2014.08.015

PMID

25231629

Abstract

Previous studies have demonstrated that combined total sleep deprivation (Wake therapy), sleep phase advance, and bright light therapy (Triple Chronotherapy) produce a rapid and sustained antidepressant effect in acutely depressed individuals. To date no studies have explored the impact of the intervention on unipolar depressed individuals with acute concurrent suicidality. Participants were suicidal inpatients (N = 10, Mean age = 44 ± 16.4 SD, 6F) with unipolar depression. In addition to standard of care, they received open label Triple Chronotherapy. Participants underwent one night of total sleep deprivation (33-36 h), followed by a three-night sleep phase advance along with four 30-min sessions of bright light therapy (10,000 lux) each morning. Primary outcome measures included the 17 item Hamilton depression scale (HAM17), and the Columbia Suicide Severity Rating Scale (CSSRS), which were recorded at baseline prior to total sleep deprivation, and at protocol completion on day five. Both HAM17, and CSSRS scores were greatly reduced at the conclusion of the protocol. HAM17 scores dropped from a mean of 24.7 ± 4.2 SD at baseline to a mean of 9.4 ± 7.3 SD on day five (p = .002) with six of the ten individuals meeting criteria for remission. CSSRS scores dropped from a mean of 19.5 ± 8.5 SD at baseline to a mean of 7.2 ± 5.5 SD on day five (p = .01). The results of this small pilot trial demonstrate that adjunctive Triple Chronotherapy is feasible and tolerable in acutely suicidal and depressed inpatients. Limitations include a small number of participants, an open label design, and the lack of a comparison group. Randomized controlled studies are needed.

Language: en